Advertisement
The presentation will be accessible to all interested parties at 8 a.m.Eastern Time, Tuesday, Sept. 11, 2007, through a live audiocast on theinvestor relations section of Hospira's Web site at www.hospirainvestor.com.Listeners should log on approximately 10 minutes in advance to ensure propercomputer setup to receive the audiocast. The slides accompanying thepresentation will be available on the Hospira Web site at 7:45 a.m. EasternTime. A replay will be available on the Hospira Web site approximately 24hours after the live presentation until Sept. 25.
Advertisement
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication deliverycompany dedicated to Advancing Wellness(TM) by developing, manufacturing andmarketing products that help improve the productivity, safety and efficacy ofpatient care. In February 2007, Hospira acquired Mayne Pharma Limited tobecome the world leader in specialty generic injectable pharmaceuticals. With70 years of service to the hospital industry, Hospira's portfolio includes oneof the industry's broadest lines of generic acute-care and oncologyinjectables, which help address the high cost of proprietary pharmaceuticals;and integrated solutions for medication management and infusion therapy.Headquartered north of Chicago in Lake Forest, Ill., Hospira has approximately15,000 employees worldwide. Hospira's news releases and other information canbe found at www.hospira.com.
SOURCE Hospira, Inc.
